Fas (Tnfrsf6, Apo-1, CD95) is a death receptor involved in apoptosis induced in many cell types. Fas have been shown to be expressed by insulin-producing beta cells in mice and humans. However, the importance of Fas in the development of autoimmune diabetes remains controversial. To further evaluate the importance of Fas in pathogenesis of diabetes, we generated NOD mice (nonobese diabetic mice developing spontaneous autoimmune diabetes) with beta cell-specific expression of a dominant-negative point mutation in a death domain of Fas, known as lpr cg or Fas cg . Spontaneous diabetes was significantly delayed in NOD mice expressing Fas cg , and the effect depended on the expression level of the transgene. However, Fas cg -bearing mice were still sensitive to diabetes transferred by splenocytes from overtly diabetic NOD mice. At the same time, Fas cg expression did neutralize the accelerating effect of transgenic Fas-ligand expressed by the same beta cells. Thus, both Fas-dependent and -independent mechanisms are involved in beta cell destruction, but interference with the Fas pathway early in disease development may retard or prevent diabetes progression.
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I
n autoimmune diabetes, pancreatic beta cells are destroyed by effector lymphocytes, leading to the loss of insulin production and hyperglycemia (1, 2) . Both CD8 ϩ and CD4 ϩ T cells contribute to the process (3), and several mechanisms of beta cell death are most likely involved (reviewed in refs. 4 and 5) . We and others (6) (7) (8) found that triggering of Fas (Apo-1 and CD95) expressed on beta cells leads to their death and, subsequently, to diabetes. In our transgenic model (6) , Fas ligand (FasL) was expressed in the beta cells of nonobese diabetic (NOD) mice. Although the original purpose of these experiments was to protect islet cells against autoaggressive T cells, mice that expressed FasL under the control of rat insulin promoter (RIP-FasL) (6) or human insulin promoter (9) demonstrated acceleration of both spontaneous and transferred diabetes. To explain this acceleration, a model has been suggested that predicts that transferred lymphocytes or their products induce Fas expression on beta cells, making them more susceptible to FasL-mediated killing. Normally, FasL involved in beta cell killing is expressed by effector T cells (10, 11) . However, in the case of RIP-FasL transgenics, the ectopic expression of FasL accelerates the killing, most likely by a fratricide mechanism.
To further study the involvement of Fas in the destruction of insulin-producing cells, we used mice with a natural Fas mutation Ϫlpr (12). We also produced NOD mice with dominantnegative mutations of Fas-lpr cg called Fas cg here (13) , which expressed the transgene selectively in the islets of Langerhans.
Materials and Methods

Generation of the RIP-Fas cg DNA Construct and Evaluation of Its
Transgenic Expression. The plasmid containing the Fas cDNA insert was a generous gift of S. Nagata (Department of Genetics, Osaka University Medical School, Osaka). A single nucleotide change (leading to I246N change in protein sequence) in Fas cDNA coding for the lpr cg (Fas cg ) mutation was introduced by the PCR-directed overlap-extension method, using Fas cg 5Ј-AAATTTGCAC-GAGAAAATAACAACAAGGAGG-3Ј forward and 5Ј-CCTC-CTTGTTGTTATTTTCTCGTGCAAATTT-3Ј reverse primers. Simultaneously, 5Ј-GCATCTCGAGGCCACCATGCTGTG-GATCTGGGCT-3Ј forward and 5Ј-CGTACTCGAGTCACTC-CAGACATTGTCC-3Ј reverse primers were used to introduce flanking XhoI sites for subcloning of the final PCR product into the rat insulin 2 promoter or (RIP)-containing vector (6, 14, 15) . Orientation of the insert was verified by restriction analysis and sequencing, and the HinDIII fragment was used for direct injection into NOD oocytes. Several transgene-bearing founders were identified by PCR with the above-listed Fas cg forward primer and a reverse 5Ј-CCACAAACAACCCAAGAGCAC-3Ј primer specific for an exon of the E␣ gene, which is part of the expression vector.
Transgene expression analysis of RIP-Fas cg transgene expression was performed by RT-PCR using RNA isolated from pancreata by the guanidine thiocyanate-cesium chloride centrifugation method (16) . cDNA was synthesized using the Superscript First-Strand Synthesis kit (Invitrogen) and amplified using Fas cg forward and E␣ reverse primers. Amplification with hypoxanthine phosphoribosyltransferase (HPRT)-specific primers (17) was used as a control for cDNA quality. Diabetes Transfer Experiments. Diabetes induction was performed using both adoptive transfer of the total splenocyte population from diabetic NOD mice and injection of insulin-specific, K drestricted T cells of the TGNFC8 clone (IS-CD8 ϩ cells) (11, 18) . Splenocytes (1.5 ϫ 10 7 ) were injected i.v. into irradiated (725 rad, 24 h in advance) recipients. Both males and females 6-9 weeks of age were used as recipients. No sex-or age-dependent differences were found in the incidence or time of onset of diabetes, and results were therefore pooled. Transfer into the host animals carrying the scid mutation was performed without irradiation. The recipients of splenocyte transfers were monitored for 50 days for diabetes development. The incidence of diabetes was assessed by monitoring glucose levels in urine by using Diastix reagent strips (Bayer, Elkhart, IN). IS-CD8 ϩ cells were maintained in vitro as described (11, 19) in Click's medium (Irvine Scientific, Santa Ana, CA) supplemented with 5% FCS (Sigma), 2 ϫ 10 Ϫ5 M 2-mercaptoethanol (Bio-Rad), 100 units͞ml penicillin and 100 g͞ml streptomycin (Life Technologies, Rockville, MD), 2 mM L-glutamine (Life Technologies), Immunohistochemical and Histological Studies. Spleens and pancreata from newly diabetic animals were used. For immunostaining, 7-m-thick cryostat sections of organs fresh-frozen in OCT compound (Sakura Finetek, Torrance, CA) were fixed in acetone at Ϫ20°C for 3 min, air-dried for 2 h, stained for 1 h at room temperature with anti-Gr-1͞Ly6G (clone RB6-8C5) and FITCconjugated anti-CD8 (clone 53.6-72) monoclonal antibodies (both from BD Biosciences), washed, and stained with rhodaminelabeled donkey anti-rat Ig secondary antibodies (Jackson ImmunoResearch). After the final wash, slides were mounted in Slowfade Light mounting medium (Molecular Probes) and examined using fluorescent microscopy. Pancreata for histological studies were fixed overnight in Bouin's fixative (20) , paraffin-embedded, sectioned, and stained with hematoxylin͞eosin according to standard protocol.
Statistical Analysis. Analysis of the statistical significance of the observed differences between various groups of mice in the performed experiments was done using SUPERANOVA software (Microsoft), using Fisher's protected least significant difference (LSD) test at a significance level of 0.05. In addition, statistical analysis of differences in spontaneous diabetes development rates was performed using the Cox proportional hazard model and permutation test (21) .
Results and Discussion
Acceleration of Diabetes in NOD.RIP-FasL Mice Is Not Caused by
Neutrophil Activation. Following our report on RIP-FasL transgenic mice (6), other groups published their results showing that FasL expressed in the islets was causing the death of beta cells and, subsequently, diabetes (9, 22, 23) . In some studies, activated neutrophils were found to infiltrate the pancreas (22, 23) (24, 25) ], causing infiltration of the islets. These studies differed from ours in the use of different mouse strains as recipients of the FasL transgene, and of an extended promoter region. In one case (22) , mice were infected with an adenovirus carrying FasL. All of these factors (the genetic background of transgene carriers, a possible role for additional sequences transferred with a longer promoter region, or the presence of adenoviral sequences) could contribute to neutrophil activation. Clearly, we needed to determine the extent to which neutrophils contribute to the acceleration of diabetes in our RIP-FasL transgenic NOD mice during spontaneous development of disease. Histological examination of spontaneously diabetic NOD.RIP-FasL transgenic mice failed to show any significant neutrophil accumulation compared with that in diabetic nontransgenic NOD animals ( Fig. 1) , as determined by morphological and immunohistochemical analyses. For the latter, tissues were stained with anti-Gr-1 (Ly6G) monoclonal antibodies, reported to specifically recognize neutrophils (26, 27) , and were used for the neutrophil detection in the islets of Langerhans (23) . Whereas Gr-1 ϩ cells were evident in the spleen (Fig. 1E) , only few GR-1 ϩ cells were found in the infiltrated islets. Overall, only Ϸ20% of islets in both nontransgenic and RIP-FasL transgenic NOD mice contained detectable neutrophils (1-2 per islet).
Moreover, RIP-FasL transgenic mice homozygous for the scid mutation (NOD.RIP-FasL-scid), which have no lymphocytes but normal neutrophil counts, did not develop spontaneous diabetes (a group of 10 female animals observed for Ͼ30 weeks); if neutrophils were responsible, one would anticipate that these mice would develop the disease. It could be argued that prior damage induced by lymphocytes is required for the homing of neutrophils to the islets, but that argument cannot explain why FasL transgenic animals on the B6 background with no prior islet damage experience neutrophil infiltration (22) . In summary, we failed to find any prominent role for neutrophils in our model of diabetes accelerated by ectopic expression of FasL in beta cells.
NOD-RIP.FasL Mice Lacking Fas Expression Do Not Show Accelerated
Disease in a Transfer Model of Diabetes. We originally found that NOD mice homozygous for the lpr mutation and thus lacking functional Fas molecules (NOD-lpr mice) were resistant to the development of spontaneous diabetes (6) . This was later confirmed by another group (28) . We have also found that the transfer of IS-CD8 ϩ cells into NOD-lpr mice does not result in diabetes development (6) . Moreover, the NOD.RIP-FasL-lpr mice that we generated were resistant to IS-CD8 ϩ cells; none of five mice became diabetic, whereas all five mice in the control NOD-RIP.FasL group became diabetic within 5 days after transfer. This was an encouraging result, suggesting that FasL expressed in the beta cells requires coexpression of Fas to induce diabetes.
The drawbacks of the lpr system, however, were pointed out in several studies in which mice homozygous for the lpr mutation were shown to express elevated levels of FasL by leukocytes, thus leading to rapid elimination of the transferred T cells (29) (30) (31) . Although our experiments using the transfer of IS-CD8 ϩ cells demonstrated that these cells were infiltrating the islets of NOD-lpr mice (6), we concurred with the argument and performed a series of experiments using NOD-lpr mice transgenic for FasL, but lacking endogenous lymphocytes expressing FasL. For that, we bred NOD.RIP-FasL-scid mice to NOD-lpr mice and generated NOD.RIP-FasL-scid-lpr mice (together with their FasL Ϫ littermates). These groups of mice were injected with 1.5 ϫ 10 7 splenocytes from diabetic NOD mice. Not all of the mice became diabetic (Table 1) , and, most importantly, there was no acceleration of diabetes development in NOD-scid-lpr mice that expressed FasL. All control Fas-sufficient NOD-scid mice became diabetic, and there was an expected acceleration of diabetes in NOD-scid mice expressing FasL in beta cells (Table  1) . Three conclusions were drawn from this experiment: first, the delay in diabetes development and reduction of the fraction of NOD-scid-lpr mice that became diabetic is due to the lack of Fas signaling; second, Fas is indeed participating in the killing of beta cells via ectopic RIP-FasL, as predicted by our model (6); and third, mice with Fas deficiency still can become diabetic on adoptive transfer of effector cells (32) , indicating that other mechanisms are involved in beta cell damage. These conclusions, however, must be made with caution, because the lpr mutation (insertion of a transposon into an intron of the Fas-encoding gene) does not block Fas expression completely, but instead severely diminishes it.
Expression of Dominant-Negative Mutant Fas cg in Beta Cells Leads to
Retardation of Diabetes. To manipulate Fas signaling in beta cells without systemic disruption of Fas observed in lpr mice, we produced transgenic animals that expressed mutant Fas molecules in beta cells. Fas cg is a point mutation in the death domain of Fas that has two important properties: it blocks Fas signaling via interference with Fas oligomerization (33) , and does so in a dominant fashion in vitro and in vivo (12, 34, 35) , because it was shown to produce an lpr-like phenotype in heterozygotes (36) . We introduced this mutation into Fas cDNA by using the PCR overlap-extension method and subcloned this cDNA into a vector containing RIP. We obtained a number of NOD.RIPFas cg transgenic founder strains that differed in their levels of transgene expression. Transgene expression in two strains is shown in Fig. 2 . Subsequent analysis of diabetes frequency in these strains revealed that RIP-Fas cg mice showed some level of protection against spontaneous diabetes and that the degree of protection correlated with the level of transgene expression ( Taken together, our data indicate a significant contribution of Fas-mediated apoptosis to the destruction of insulin-producing cells and the development of diabetes. 
